{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T00:20:36Z","timestamp":1759882836515,"version":"build-2065373602"},"reference-count":20,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[1997,4,1]],"date-time":"1997-04-01T00:00:00Z","timestamp":859852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[1997,4,1]],"date-time":"1997-04-01T00:00:00Z","timestamp":859852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Journal Armed Forces India"],"published-print":{"date-parts":[[1997,4]]},"DOI":"10.1016\/s0377-1237(17)30673-1","type":"journal-article","created":{"date-parts":[[2017,6,26]],"date-time":"2017-06-26T15:00:51Z","timestamp":1498489251000},"page":"91-94","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["BORDERLINE TUBERCULOID LEPROSY: CLINICOPATHOLOGICAL EVALUATION OF MULTIDRUG THERAPY"],"prefix":"10.1016","volume":"53","author":[{"given":"PK","family":"KAR","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"RS","family":"DHAKA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S0377-1237(17)30673-1_bib1","unstructured":"WHO. A Guide to leprosy control. Edn 2. World Health Organization 1988, Geneva"},{"key":"10.1016\/S0377-1237(17)30673-1_bib2","unstructured":"WHO. Chemotherapy of leprosy for control programme. Report of a WHO study Group. WHO 1982 Tech Rep Ser 675"},{"key":"10.1016\/S0377-1237(17)30673-1_bib3","unstructured":"WHO. Chemotherapy of leprosy. Report of a WHO Study Group. WHO 1994 Tech Rep Ser 847"},{"key":"10.1016\/S0377-1237(17)30673-1_bib4","first-page":"157","article-title":"A study of relapse in paucibacillary leprosy in MDT project in Baroda District","volume":"61","author":"Chopra","year":"1990","journal-title":"Lepr Rev"},{"key":"10.1016\/S0377-1237(17)30673-1_bib5","first-page":"19","article-title":"Relapse in paucibacillary leprosy after MDT \u2013 a clinical study","volume":"58","author":"Grugni","year":"1990","journal-title":"Int J Lepr"},{"key":"10.1016\/S0377-1237(17)30673-1_bib6","first-page":"285","article-title":"Parkash 1. Prospects for elimination of leprosy in India by 2000 AD","volume":"67","author":"Rao","year":"1995","journal-title":"Indian J Lepr"},{"key":"10.1016\/S0377-1237(17)30673-1_bib7","first-page":"255","article-title":"Classification of leprosy according to immunity. A five group system","volume":"43","author":"Ridley","year":"1966","journal-title":"Int J Lepr"},{"key":"10.1016\/S0377-1237(17)30673-1_bib8","first-page":"449","article-title":"Deformity incidence in leprosy patients treated with multidrug therapy","volume":"66","author":"Rao","year":"1994","journal-title":"Indian J Lepr"},{"key":"10.1016\/S0377-1237(17)30673-1_bib9","first-page":"48","article-title":"Experience with 2 drug regimen in paucibacillary leprosy. A preliminary report","volume":"56","author":"Kaur","year":"1984","journal-title":"Indian J Lepr"},{"key":"10.1016\/S0377-1237(17)30673-1_bib10","first-page":"57","article-title":"Multidrug therapy for paucibacillary leprosy: Experience in Bombay","author":"Revankar","year":"1985","journal-title":"Indian J Lepr"},{"key":"10.1016\/S0377-1237(17)30673-1_bib11","first-page":"244","article-title":"Experience with multidrug therapy in paucibacillary leprosy","volume":"58","author":"Bhate","year":"1986","journal-title":"Indian J Lepr"},{"key":"10.1016\/S0377-1237(17)30673-1_bib12","first-page":"71","article-title":"Multidrug therapy in hospitalized leprosy cases","volume":"60","author":"Tiwari","year":"1988","journal-title":"Indian J Lepr"},{"key":"10.1016\/S0377-1237(17)30673-1_bib13","first-page":"491","article-title":"Short course treatment of paucibacillary (BT\/TT) leprosy cases","volume":"57","author":"Girdhar","year":"1985","journal-title":"Indian J Lepr"},{"key":"10.1016\/S0377-1237(17)30673-1_bib14","first-page":"409","article-title":"Preliminary appraisal of WHO recommended multiple drug regimen in paucibacillary leprosy patients in Malawi","volume":"56","author":"Boerrighter","year":"1988","journal-title":"Int J Lepr"},{"key":"10.1016\/S0377-1237(17)30673-1_bib15","first-page":"1","article-title":"Comparison of three regimens containing rifampicin for treatment of paucibacillary leprosy patients","author":"Katoch","year":"1955","journal-title":"Int J Lepr 1987"},{"key":"10.1016\/S0377-1237(17)30673-1_bib16","unstructured":"WHO. Progress towards eliminating leprosy as a public health problem. Weekly Epidemiological Record 1994; No 20: 145-51; No 21: 153-7"},{"key":"10.1016\/S0377-1237(17)30673-1_bib17","first-page":"61","article-title":"Features of relapse in PB leprosy after multi-drug therapy","volume":"67","author":"Naafs","year":"1995","journal-title":"Indian J Lepr"},{"key":"10.1016\/S0377-1237(17)30673-1_bib18","first-page":"729","article-title":"14th International Leprosy Congress. Workshop 3: Chemotherapy","volume":"61","year":"1993","journal-title":"Int J Lepr"},{"key":"10.1016\/S0377-1237(17)30673-1_bib19","first-page":"435","article-title":"Problems of Multidrug Therapy","volume":"63","author":"Ramu","year":"1991","journal-title":"Indian J Lepr"},{"key":"10.1016\/S0377-1237(17)30673-1_bib20","first-page":"1","article-title":"Duration of MDT for paucibacillary leprosy","volume":"64","author":"Ramu","year":"1992","journal-title":"Indian J Lepr"}],"container-title":["Medical Journal Armed Forces India"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0377123717306731?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0377123717306731?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T11:46:04Z","timestamp":1759837564000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0377123717306731"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,4]]},"references-count":20,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1997,4]]}},"alternative-id":["S0377123717306731"],"URL":"https:\/\/doi.org\/10.1016\/s0377-1237(17)30673-1","relation":{},"ISSN":["0377-1237"],"issn-type":[{"type":"print","value":"0377-1237"}],"subject":[],"published":{"date-parts":[[1997,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"BORDERLINE TUBERCULOID LEPROSY: CLINICOPATHOLOGICAL EVALUATION OF MULTIDRUG THERAPY","name":"articletitle","label":"Article Title"},{"value":"Medical Journal Armed Forces India","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S0377-1237(17)30673-1","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 1997 Elsevier B.V. on behalf of Director General, Armed Forces Medical Services. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}